Drug Database
Back to search

France· FR:60346811

POMALIDOMIDE EG 4 mg, gélule

A pomalidomide product containing pomalidomide, registered in France by EG LABO - LABORATOIRES EUROGENERICS. The same ATC class is registered in 17 of our 19 countries.

ATC L04AX06

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPOMALIDOMIDE EG 4 mg, géluleATCL04AX06REGISTER NO.FR:60346811PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pomalidomideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pomalidomide is registered in 17 of 19 countries.

Countries holding a registration under ATC L04AX06 (pomalidomide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search pomalidomide products by name

Pomalidomide · ATC L04AX06

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pomalidomide costs, country by country.

Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pomalidomide · price per daily dose (3 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$255.48
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
POMALIDOMIDE
Manufacturer
EG LABO - LABORATOIRES EUROGENERICS
Country
France (FR)
ATC code
L04AX06
ATC class
Pomalidomide
Defined daily dose
3 mg, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930309131
    plaquette(s) PVC (ACLAR) polytrifluorochloroéthylène aluminium de 21 gélule(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

277 interactions on record for pomalidomide.

Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pomalidomide against other medicinesHow interaction checks work

Pomalidomide · interactions on record

277 records

  • 64 severe
  • 213 moderate

Most severe, free to view

  • ErythropoietinB03XA01severe
  • Darbepoetin alfaB03XA02severe
  • PeginesatideB03XA04severe
  • C1-inhibitor, plasma derivedB06AC01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pomalidomide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pomalidomide products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Pomalidomid +pharma, Pomalidomid Devatis
  • Belgium · Pomalidomide Eg, Pomalidomide Eugia
  • Bulgaria · Помалидомид Devatis, Помалидомид Булгермед
  • Cyprus · Pomalidomide, Pomalidomide Adalvo
  • Czechia · Pomalidomid Sanexcel, Pomalidomide Abdi
  • Germany · Pomadel, Pomalidomid 123 Acurae Pharma
  • Denmark · Pomalidomid Devatis, Pomalidomid Grindeks
  • Estonia · Pomalidomide Grindeks, Pomalidomide Olpha
  • Spain · Pomalidomida Abdi, Pomalidomida Erawya
  • Finland · Pomalidomid Avansor, Pomalidomid Devatis
  • United Kingdom (Northern Ireland) · Pomalidomide, Pomalidomide Amarox
  • Greece · Polidma, Pomalidomide Anabiosis
  • Hungary · Pomalidomid Onkogen, Pomalidomide Grindeks
  • Ireland · Pomalidomide Clonmel, Pomalidomide Grindeks
  • Iceland · Imnovid, Pomalidomide Accord
  • Italy · Pomalidomide Abdi, Pomalidomide Aurobindo
  • Liechtenstein · Imnovid, Pomalidomide Accord
  • Lithuania · Pomalidomide Grindeks, Pomalidomide Olpha
  • Luxembourg · Pomalidomide Eg, Pomalidomide Eugia
  • Latvia · Pomalidomide Grindeks, Pomalidomide Olpha
  • Malta · Pomalidomide, Pomalidomide Clonmel
  • Netherlands · Polidma, Pomalidomide Adalvo
  • Norway · Imnovid, Pomalidomid Devatis
  • Poland · Pomalidomid Reig Jofre, Pomalidomide Eugia
  • Portugal · Pomalidomida Aurobindo, Pomalidomida Bluepharma
  • Romania · Pomalidomidă Dr. Reddy’s, Pomalidomidă Grindeks
  • Sweden · Davunfite, Pomalidomid Avansor
  • Slovenia · Pomadel, Pomalidomid Grindeks
  • Slovakia · Pomalidomid Grindeks, Pomalidomid Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dcf7d918-adb0-40b6-845a-fa6ad5b2460e
GET /v1/drugs/dcf7d918-adb0-40b6-845a-fa6ad5b2460e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60346811",
  "date_amm": "2025-01-09",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "POMALIDOMIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about pomalidomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console